Aclaris Therapeutics (ACRS) Enterprise Value (2015 - 2026)
Aclaris Therapeutics' Enterprise Value came in at $648.11 million for Q2 2026, compared with $54.02 million a year earlier and up 54.9% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Enterprise Value (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Aclaris Therapeutics reported Enterprise Value of $356.04 million; for FY2025, it came in at $271.95 million, up 248.2% from FY2024.
- Enterprise Value carries a five-year compound annual growth rate of 2.7% (FY2020 to FY2025).
- Going back by year, Enterprise Value was $78.1 million in FY2024, -$44.67 million in FY2023, $832.78 million in FY2022 (+19.2%) and $698.85 million in FY2021 (+194.0%).
- The Q2 2026 figure represents the highest quarterly Enterprise Value since Q4 2022.
- The fastest year-over-year change in Enterprise Value over five years came in Q1 2026 (growth of 593.3%), and the weakest in Q1 2023 (a decline of 57.9%).
- Business Quant data shows ACRS's Enterprise Value at $418.28 million (Q1 2026), $271.95 million (Q4 2025) and $109.94 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Aclaris Therapeutics | 759.25 Mn | 759.25 Mn | 1.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 648.11 Mn |
| Mar 31, 2026 | 418.28 Mn |
| Dec 31, 2025 | 271.95 Mn |
| Sep 30, 2025 | 109.94 Mn |
| Jun 30, 2025 | 54.02 Mn |
| Mar 31, 2025 | 60.33 Mn |
| Dec 31, 2024 | 78.10 Mn |
| Sep 30, 2024 | -45.59 Mn |
| Jun 30, 2024 | -32.63 Mn |
| Mar 31, 2024 | -39.82 Mn |
| Dec 31, 2023 | -44.67 Mn |
| Sep 30, 2023 | 382.06 Mn |
| Jun 30, 2023 | 614.11 Mn |
| Mar 31, 2023 | 372.89 Mn |
| Dec 31, 2022 | 832.78 Mn |
| Sep 30, 2022 | 801.48 Mn |
| Jun 30, 2022 | 682.08 Mn |
| Mar 31, 2022 | 884.73 Mn |
| Dec 31, 2021 | 698.85 Mn |
| Sep 30, 2021 | 904.20 Mn |
API Access
Aclaris Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();